Drug toxicity and safety
Drug toxicity and safety
Drug toxicity and safety
Therapeutic index
The therapeutic index is a quantitative measurement of the relative safety of a drug. It is a comparison of the
amount of a therapeutic agent that causes the therapeutic effect to the amount that causes toxicity.
Therapeutic index = Median lethal dose (LD 50)/median effective dose (ED 50)
1. Predictable reaction/Type A
Expected
Side effects, toxic effects and consequences of drug withdrawal.
They are more common, dose related and mostly preventable and reversible.
Eg:
2. Unpredictable reaction/Type B
Unexpected
These are based on peculiarities of the patient and not on drug’s known actions; include
allergy and idiosyncrasy.
They are less common, often non-dose related, generally more serious and require
withdrawal of the drug
Eg:
Type A Type B
Incidence rate is high Incidence rate is lower
Mortality rate is rare or very low Mortality rate is higher
Reduction in dose can minimize these adverse Reduction in dose can’t minimize these adverse
effects effects
Side effects
These are undesirable effects which are observed even with the therapeutic doses of the
drug. These ADRs are usually mild and manageable.
E.g.:
o Dicyclomine causes dryness of mouth at therapeutic doses
o Promethazine produces sedation which is unrelated to its antiallergic action
o Estrogens cause nausea which is unrelated to their antiovulatory action
o Codeine used for cough produces constipation
Toxic effects
These are exaggerated form of side effects which occur either due to overdoses or after
prolonged use of the drug.
Eg: Hyperpyrexia, hallucination, delirium due to atropine
Hepatic necrosis due to paracetamol
Nephrotoxicity, ototoxicity due to streptomycin
Respiratory failure due to morphine
Idiosyncrasy
These are harmful and sometimes fatal reactions that occur in a small minority of
individuals.
It is genetically determined abnormal reactivity to a chemical substance.
e.g.: Barbiturates cause excitement and mental confusion in some individuals.
Quinine/quinidine cause cramps, diarrhoea, purpura, asthma and vascular collapse in some
patients.
Allergic responses to drug occur when there has been previous exposure to drug and when
this sensitized individual is re-exposed to the same drug again. Eg: Penicillin, salicylates
Immunologically mediated reaction
occurs even with much smaller doses
o E.g.: Penicillins, cephalosporins, sulfonamides, tetracyclines, quinolones,
antitubercular drugs, phenothiazines, salicylates, carbamazepine, allopurinol, ACE
inhibitors, methyldopa, hydralazine, local anaesthetics
Two types: Humoral and Cell mediated
o A. Humoral: Three types
Type-I (anaphylactic) reactions:
Mediated by IgE
Antibodies (IgE) are produced which get fixed to the mast cells.
On exposure to the drug, AG: AB reaction takes place on the mast
cell surface
Release of mediators like histamine, 5-HT, leukotrienes, PGs, etc
Results in urticaria, itching, angioedema, bronchospasm, rhinitis or
anaphylactic shock
Type-II (cytolytic) reactions:
Mediated by IgG or IgM
Drug + component of a specific tissue cell act as AG.
The resulting antibodies (IgG, IgM) bind to the target cells
on re-exposure, AG: AB reaction takes place on the surface of these
cells, complement is activated, and cytolysis occurs
e.g., thrombocytopenia, agranulocytosis, aplastic anaemia,
haemolysis, organ damage (liver, kidney, muscle), systemic lupus
erythematosus
Type-III (retarded, Arthus) reactions:
Immune complex mediated
AG:AB complex gets deposited on vascular endothelium.
Manifestations are rashes, serum sickness (fever, arthralgia,
lymphadenopathy), polyarteritis nodosa, Stevens-Johnson
syndrome.
o Cell mediated:
Type-IV (delayed hypersensitivity) reactions:
mediated through production of sensitized T-lymphocytes carrying
receptors for the AG.
On contact with the AG these T cells produce lymphokines which
attract granulocytes and generate an inflammatory response
e.g., contact dermatitis, some rashes, fever, photosensitization.
The reaction generally takes > 12 hours to develop.
Tetratogenecity
Capacity of a drug to cause fetal abnormalities when administered to the pregnant mother
Drugs can affect the foetus at 3 stages—
o (i) Fertilization and implantation—conception to 17 days—failure of pregnancy
which often goes unnoticed.
o (ii) Organogenesis—18 to 55 days of gestation—deformities are produced.
o (iii) Growth and development—56 days onwards — developmental and functional
abnormalities can occur
It is, therefore, wise to avoid all drugs during pregnancy
Iatrogenic disease/Drug induced disease
These are the diseases induced by drug therapy. These also occur when a drug is suddenly
discontinued.
Functional disturbances (disease) caused by drugs which persist even after the offending
drug has been withdrawn and largely eliminated
e.g.: Peptic ulcer by salicylates and corticosteroids.
Parkinsonism by phenothiazines and other antipsychotics.
Hepatitis by isoniazid.
DLE by hydralazine.
Photosensitivity
Drug dependence